Prototheca wickerhamii olecranon bursitis successfully treated with adjunctive systemic itraconazole.

Pathology

1Department of Microbiology, Melbourne Pathology 2Infectious Diseases Department, Alfred Hospital, Melbourne, Vic, Australia.

Published: June 2015

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000266DOI Listing

Publication Analysis

Top Keywords

prototheca wickerhamii
4
wickerhamii olecranon
4
olecranon bursitis
4
bursitis treated
4
treated adjunctive
4
adjunctive systemic
4
systemic itraconazole
4
prototheca
1
olecranon
1
bursitis
1

Similar Publications

Background: Protothecosis in dogs is a rare, yet emerging disease, distinguished by its often-aggressive clinical course and high fatality rate. Our study was conducted to enhance treatment protocols for affected dogs by better understanding the genetic diversity and drug resistance patterns of Prototheca species.

Objectives: To identify species and drug susceptibility profiles of an international collection of 28 Prototheca strains isolated from cases of protothecosis in dogs.

View Article and Find Full Text PDF

Phenotypic and molecular characterization of Prototheca wickerhamii from a Brazilian case of human systemic protothecosis.

PLoS Negl Trop Dis

November 2024

Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Brazil.

The genus Prototheca (alga) comprises a unique group of achlorophyllic saprotrophic and mammalian pathogen species. Despite its rare occurrence in humans and animals, protothecosis is considered an emerging clinical entity with relevance in immunocompromised patients. In this study, the characterization of spherical structures with endospores recovered from a blood culture in an HIV patient was investigated using phenotypic and molecular methodologies.

View Article and Find Full Text PDF

is an opportunistic pathogen that can infect both humans and animals, of which () being the most significant pathogenic green algae. The incidence of human diseases caused by has been on the rise, yet there is a significant gap in genetic research pertaining to the pathophysiological aspects of these infections. The aim of this study is to present the whole genome data from the clinical isolate InPu-22_FZ strain and to understand its genomic characteristics through comparative genomic analysis and phylogenetic tree analysis.

View Article and Find Full Text PDF

Combinatory effect of ALA-PDT and itraconazole in the treatment of cutaneous protothecosis.

Photodiagnosis Photodyn Ther

October 2024

Department of Dermatology and Venereology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, #107 Yanjiang West Rd., Guangzhou, Guangdong 510120, China. Electronic address:

Article Synopsis
  • Protothecosis, a rare subcutaneous infection caused by Prototheca wicherhamii, often goes misdiagnosed and lacks a standardized treatment; combined oral itraconazole and 5-aminolevulinic acid photodynamic therapy (ALA-PDT) has been explored for therapy.* -
  • The study examined the effects of different ALA concentrations and light doses on inhibiting P. wickerhamii growth and utilized transmission electron microscopy (TEM) to observe cellular changes, confirming ALA-PDT disrupts the cell structure of the fungus.* -
  • Treatment of a patient showed that the combined therapy was effective over a 9-week period, with ALA-PDT enhancing the effectiveness of itraconazole
View Article and Find Full Text PDF
Article Synopsis
  • Cutaneous protothecosis is an uncommon infection that affects the skin and can spread systemically, requiring long-term treatment with medications that may have harmful side effects.
  • The case study focuses on a patient whose skin infection did not respond to standard triazole treatment.
  • The patient showed significant improvement after being treated with a new oral formulation of amphotericin B, which was effective without causing any toxicity.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!